Kowalski A, Mueller T C, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3523413 A1, 2015-01-23.
O'Brien P Q, Mueller T, Park J H. "Method for the Synthesis of Ethyl 4-(2-(benzo[d][1,3]dioxol-5-ylamino)-2-oxoethyl)piperazine-1-carboxylate" [P]. US Patent, US 9980985 B2, 2015-01-16.
Johansson L, Schröder R, Mueller T C. "A Process for Preparing High-Purity Ethyl 4-(2-(benzo[d][1,3]dioxol-5-ylamino)-2-oxoethyl)piperazine-1-carboxylate" [P]. European Patent, EP 3022643 A1, 2024-04-15.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2017, 193, 3874-3894.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2025, 1022, (8), 6361-6379.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 4-(2-(benzo[d][1,3]dioxol-5-ylamino)-2-oxoethyl)piperazine-1-carboxylate Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2017, 2006, 6793-6809.